[go: up one dir, main page]

MX2012001693A - Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida. - Google Patents

Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida.

Info

Publication number
MX2012001693A
MX2012001693A MX2012001693A MX2012001693A MX2012001693A MX 2012001693 A MX2012001693 A MX 2012001693A MX 2012001693 A MX2012001693 A MX 2012001693A MX 2012001693 A MX2012001693 A MX 2012001693A MX 2012001693 A MX2012001693 A MX 2012001693A
Authority
MX
Mexico
Prior art keywords
pressurized metered
stable
metered dose
dose inhalers
corrosive
Prior art date
Application number
MX2012001693A
Other languages
English (en)
Other versions
MX353975B (es
Inventor
Julio Cesar Vega
Original Assignee
Pablo Cassara Srl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45607025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012001693(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pablo Cassara Srl Lab filed Critical Pablo Cassara Srl Lab
Publication of MX2012001693A publication Critical patent/MX2012001693A/es
Publication of MX353975B publication Critical patent/MX353975B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a inhaladores farmacéuticos presurizados de dosis medida (IDM), que contienen al menos un haluro disuelto, una sustancia farmacéutica suspendida, una sustancia farmacéutica disuelta y un cosolvente, estabilizados químicamente y también contra la corrosión metálica mediante la adición de un ácido, un agente suspensor insaturado y agua.
MX2012001693A 2011-02-10 2012-02-08 Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida. MX353975B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/024,414 US20120204871A1 (en) 2011-02-10 2011-02-10 Stable, non-corrosive formulations for pressurized metered dose inhalers

Publications (2)

Publication Number Publication Date
MX2012001693A true MX2012001693A (es) 2012-08-29
MX353975B MX353975B (es) 2018-02-07

Family

ID=45607025

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012001693A MX353975B (es) 2011-02-10 2012-02-08 Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida.
MX2012003303A MX2012003303A (es) 2011-02-10 2012-03-16 Formulaciones medicinales en aerosol que no dañan la capa de ozono y con bajo efecto invernadero.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2012003303A MX2012003303A (es) 2011-02-10 2012-03-16 Formulaciones medicinales en aerosol que no dañan la capa de ozono y con bajo efecto invernadero.

Country Status (7)

Country Link
US (2) US20120204871A1 (es)
EP (1) EP2486914A3 (es)
AR (1) AR085059A1 (es)
BR (1) BR102012002923A2 (es)
CL (1) CL2012000327A1 (es)
DE (1) DE102012102218A1 (es)
MX (2) MX353975B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10610512B2 (en) 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2016164508A1 (en) * 2015-04-10 2016-10-13 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
WO2016187156A1 (en) * 2015-05-21 2016-11-24 Island Breeze Systems Ca, Llc Propellant based metered dose inhaler and food applicators and applicators
EA202092976A1 (ru) * 2018-06-04 2021-03-16 Люпин Инк. Устойчивые фармацевтические композиции для дозированных ингаляторов под давлением
IL305534A (en) * 2021-03-23 2023-10-01 1232176 B C Ltd device for the treatment of anaphylaxis
WO2025128797A1 (en) 2023-12-13 2025-06-19 Blue Evolution, Inc Ecofriendly, biodegradable biological polysaccharide composition for packaging materials

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4132176C2 (de) 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
RO117414B1 (ro) 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
UA99466C2 (en) * 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound

Also Published As

Publication number Publication date
CL2012000327A1 (es) 2014-07-11
US20120204871A1 (en) 2012-08-16
AR085059A1 (es) 2013-08-07
MX2012003303A (es) 2012-09-18
DE102012102218A1 (de) 2013-06-20
MX353975B (es) 2018-02-07
US20120207685A1 (en) 2012-08-16
EP2486914A2 (en) 2012-08-15
BR102012002923A2 (pt) 2013-07-23
EP2486914A3 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
MX2012001693A (es) Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida.
AR130238A2 (es) Método para reducir la cantidad del producto de degradación dp3 durante la vida de estante de una composición farmacéutica en solución para aerosol y uso de un envase de aerosol asociado
MX2014004960A (es) Composiciones liposomales combinadas para terapia contra el cancer.
UA111343C2 (uk) Фармацевтична композиція, що містить мометазону фуроат та азеластину гідрохлорид, для назального введення
UA115139C2 (uk) Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
EP2792746A4 (en) OLIGONUCLEOTIDE AND THERAPEUTIC FOR HYPERLIPIDEMIA WITH THIS AS AN ACTIVE SUBSTANCE
PH12016501342A1 (en) Intranasal pharmaceutical dosage forms comprising naloxone
MX388963B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral
EP2799543A4 (en) HUMANIZED ANTI-EPIREGULIN ANTIBODY AND CANCER THERAPY AGENTS WITH THESE ANTIBODY AS ACTIVE AGENT
MY191380A (en) Stabilized fixed dose drug composition having mometasone and olopatadine
PH12013502270A1 (en) Compositions, methods & systems for respiratory delivery of two or more active agents
PH12013500477A1 (en) Aqueous drug delivery system comprising off-flavor masking agent
BR112017004798A2 (pt) composição farmacêutica que contém um derivado de ácido hidroxâmico ou um seu sal
WO2012016845A3 (en) Pharmaceutical formulation comprising a phosphodiesterase inhibitor
MY160458A (en) Stable ready to use injectable paracetamol formulation
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
WO2013104892A8 (en) Application of high dose compounds via inhalation
EA201591188A1 (ru) Доставка глатирамера ацетата через слизистую оболочку
IN2014CN02343A (en) Oral formulations containing hyaluronic acid for sustained drug release
MX2009011206A (es) Proceso para dosificar sistemas de suministro de farmaco autoemulsificante.
CO7310521A2 (es) Composición farmaceútica que tiene fluidez mejorada, agente medicional, y método para la producción y uso del mismo
UA111123C2 (uk) Застосування комбінованого терапевтичного засобу для лікування риніту
FR2937867B1 (fr) Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
GEP201606594B (en) Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations)
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine

Legal Events

Date Code Title Description
FG Grant or registration